Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

Friday’s trading has closed, but KERX is being traded in the after-hours session. After-Hours quote »
12.70
Delayed Data
As of 3:59pm ET
 -0.08 / -0.63%
Today’s Change
10.85
Today|||52-Week Range
18.48
-10.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues5.0M0.007.0M10.8M
 
 
 
 
Cost of Goods Sold0.000.00--495.0K
 
 
Depreciation And Amortization47.0K35.0K54.0K--
 
 
 
 
 
Operating ExpensesGross Income5.0M-35.0K--10.3M
 
 
 
 
General Expenses33.7M27.0M53.0M121.6M
 
 
 
 
 
Research And Development27.0M20.0M33.7M51.5M
 
 
 
 
 
Total Operating Expenses33.7M27.1M53.1M122.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.7M-27.1M-46.1M-111.2M
 
 
 
 
 
Extraordinary Charge0.000.00-1.0M--
 
 
Other Expenses221.0K1.7M161.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-28.4M-25.4M-46.7M-110.8M
 
 
 
 
 
Income Taxes0.000.000.00-700.0K
 
 
Discontinued Operations246.0K0.000.00--
 
 
Extraordinary Items0.002.6M0.00--
 
 
Net Income-28.1M-25.4M-46.7M-111.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS67.4M71.6M81.0M91.0M
 
 
 
 
 
Shares To Calculate EPS Diluted67.4M71.6M81.0M91.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.32-$0.58-$1.23
 
 
 
 
 
EPS Diluted-$0.42-$0.35-$0.58-$1.23
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account